Torii Pharmaceutical Co., Ltd.

    Torii Pharmaceutical Co., Ltd.

    TTSE:4551
    23,528,002,435,891,200.00
    JPY
    +23,527,990,251,590,704.00
    (+193,100,869.86%)
    19.39P/E
    2013 Y
    2014 Y
    2014 Y
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    1,847.71
    2,053.21
    1,537.17
    2,204.13
    2,146.46
    2,286.5
    2,230.03
    1,531.56
    1,484.69
    1,672.55
    1,740.06
    1,944.02
    2,149.5
    2,036.89
    Basic EPS, GAAP
    65.33
    118.44
    85.48
    124.63
    101.22
    168.21
    41.5
    974.82
    124.44
    120.1
    140.36
    146.56
    179.36
    186.94
    Free Cash Flow per Basic Share
    -42.37
    -35.76
    -52.76
    122.12
    94.19
    198.22
    270.38
    1,494.37
    -137.22
    -18.87
    76.12
    -118.8
    123.05
    - -
    Dividend per Share
    40
    40
    40
    43.99
    48.42
    47.99
    47.99
    47.98
    47.96
    47.98
    47.97
    125.96
    129.98
    - -
    Book Value per Share
    517.68
    596.2
    641.73
    722.4
    781.67
    901.89
    895.43
    1,821.47
    1,897.14
    1,968.78
    2,060.75
    2,080.89
    2,129.86
    4,087.12
    Tangible Book Value per Share
    2,687.54
    2,770.01
    2,805.83
    2,892.93
    2,946.95
    3,076.76
    3,081.14
    4,010.79
    4,082
    4,147.01
    4,224.6
    4,259.1
    4,311.84
    4,272.06
    Basic Weighted Avg Shares
    28
    28
    28
    28
    28
    28
    28
    28
    28
    28
    28
    28
    28
    28
    Sales/Revenue/Turnover
    52,292
    58,108
    43,502
    62,377
    60,206
    64,134
    62,550
    42,997
    41,699
    46,987
    48,894
    54,637
    60,425
    57,247
    Operating Margin (%)
    5.35
    8.59
    9.28
    7.89
    6.35
    9.8
    7.92
    3.34
    11.37
    9.92
    11.34
    9.23
    11.26
    11.65
    Depreciation Expense
    1,061
    1,089
    924
    1,457
    1,339
    1,174
    1,040
    985
    582
    413
    454
    459
    408
    - -
    Net Income, GAAP
    1,849
    3,352
    2,419
    3,527
    2,839
    4,718
    1,164
    27,367
    3,495
    3,374
    3,944
    4,119
    5,042
    5,254
    Effective Tax Rate (%)
    36.84
    34.7
    36
    32.9
    29.98
    25.97
    61.55
    27.41
    17.25
    29.2
    31.07
    26.34
    25.01
    25.25
    Profit Margin (%)
    3.54
    5.77
    5.56
    5.65
    4.72
    7.36
    1.86
    63.65
    8.38
    7.18
    8.07
    7.54
    8.34
    9.18
    Working Capital
    57,523
    59,129
    60,730
    62,683
    66,813
    68,112
    64,179
    85,075
    87,281
    84,920
    78,382
    75,644
    76,487
    73,958
    LT Debt
    71
    193
    387
    725
    571
    465
    380
    294
    209
    275
    241
    22
    281
    - -
    Total Equity
    76,699
    79,016
    80,223
    82,825
    83,555
    87,117
    87,092
    113,125
    115,089
    117,014
    119,224
    120,132
    121,532
    120,442
    Return on Invested Capital (%)
    2.27
    4.12
    3.19
    3.95
    3.13
    5.34
    2.15
    0.98
    3.29
    2.81
    3.19
    3.06
    4.17
    4.15
    Return on Capital (%)
    12.83
    20.87
    13.38
    17.46
    12.84
    19.44
    4.53
    70.99
    6.65
    6.17
    6.91
    7.03
    8.47
    4.61
    Return on Common Equity (%)
    12.94
    21.27
    13.81
    18.27
    13.4
    19.98
    4.62
    71.78
    6.69
    6.21
    6.97
    7.08
    8.52
    4.61

    Capital Structure

    JPY

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    222
    - -
    - -
    LT Borrowings
    - -
    - -
    - -
    LT Finance Leases
    22
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    - -
    - -
    - -
    Market Capitalization
    96,964
    111,717
    101,889

    Working Capital

    JPY

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    88,148
    85,620
    87,165
    Cash, Cash Equivalents & STI
    44,003
    40,678
    42,174
    Accounts Receivable, Net
    28,502
    27,870
    27,883
    Inventories
    10,742
    12,077
    11,902
    Total Current Liabilities
    12,504
    13,181
    13,207
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    222
    - -
    - -
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    JPY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    4.55%
    1.45%
    1.17%
    Free Cash Flow
    -91.37%
    -231.74%
    -203.59%
    Net Income, GAAP
    222.13%
    -9.39%
    22.41%
    Sales/Revenue/Turnover
    4.88%
    7.21%
    10.59%
    Total Cash Common Dividend
    - -
    - -
    3.22%

    Quarterly Revenue

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    11,811
    13,888
    13,433
    15,505
    54,637
    2024
    13,451
    14,858
    - -
    - -
    60,425
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    -10.25
    - -
    - -
    - -
    146.56
    2024
    31.24
    - -
    - -
    - -
    179.36
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    125.96
    2024
    - -
    - -
    - -
    - -
    129.98
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business